Yan Xu
Impact in
- Molecular Biology top 1%
- Sphingolipid Metabolism and Signaling
- Metabolomics and Mass Spectrometry Studies
- Receptor Mechanisms and Signaling
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Sphingolipid Metabolism and Signaling 45
- Metabolomics and Mass Spectrometry Studies 7
- RNA Research and Splicing 4
- Receptor Mechanisms and Signaling 3
- Epigenetics and DNA Methylation 3
-
- Ovarian cancer diagnosis and treatment 12
- Co-authors
- Zhenwen Zhao (23 shared papers)Yi-jin Xiao (7 shared papers)Graham Casey (6 shared papers)Jerome Leslie Belinson (6 shared papers)Yijin Xiao (6 shared papers)Linnea M. Baudhuin (7 shared papers)Qingchun Cai (12 shared papers)Libo Yan (8 shared papers)
- Journals
- The FASEB Journal (5 papers)PLoS ONE (4 papers)Cancers (4 papers)Oncogene (4 papers)Journal of Lipid Research (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Yan Xu
95 papers receiving 8.1k citations
Yan Xu's Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 4.4k
- Reproductive Medicine 677
- Cancer Research 691
- Biochemistry 237
- Immunology 608
Countries citing papers authored by Yan Xu
This map shows the geographic impact of Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xu more than expected).
Fields of papers citing papers by Yan Xu
This network shows the impact of papers produced by Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xu. The network helps show where Yan Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 812 | |
| 2 | The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Hit paper breakdown → | 2007 | 702 |
| 3 | 1998 | 569 | |
| 4 | 2004 | 305 | |
| 5 | Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. | 1995 | 289 |
| 6 | 2017 | 263 | |
| 7 | 2018 | 246 | |
| 8 | 2001 | 209 | |
| 9 | 2007 | 196 | |
| 10 | 2006 | 178 | |
| 11 | 2000 | 145 | |
| 12 | 2012 | 144 | |
| 13 | 2013 | 137 | |
| 14 | 2006 | 135 | |
| 15 | 2011 | 135 | |
| 16 | 2009 | 129 | |
| 17 | 2010 | 129 | |
| 18 | 2010 | 126 | |
| 19 | 2011 | 124 | |
| 20 | 2005 | 115 |
About Yan Xu
Yan Xu is a scholar working on Molecular Biology, Reproductive Medicine, Cancer Research, Immunology and Oncology, having authored 95 papers that have together received 8.3k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (45 papers), Ovarian cancer diagnosis and treatment (12 papers), Cancer, Lipids, and Metabolism (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Cancer Cells and Metastasis (5 papers), RNA Research and Splicing (4 papers), Receptor Mechanisms and Signaling (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Molecular Biology (4.4k citations), Reproductive Medicine (677 citations), Cancer Research (691 citations), Biochemistry (237 citations) and Immunology (608 citations). Yan Xu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Zhenwen Zhao, Yi-jin Xiao, Graham Casey, Jerome Leslie Belinson, Yijin Xiao, Linnea M. Baudhuin, Qingchun Cai, Libo Yan, Jerold J. M. Chun and Lisam Shanjukumar Singh. Their work appears in journals such as The FASEB Journal, PLoS ONE, Cancers, Oncogene and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.